Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
about
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortalityAre positron emission tomography-computed tomography (PET-CT) scans useful in preoperative assessment of patients with peritoneal disease before cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)?Oligometastatic Disease in the Peritoneal Space with Gastrointestinal Cancer.A Prognostic Model for Predicting Overall Survival in Patients with Peritoneal Surface Malignancy of an Appendiceal Origin Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC.A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.Factors Associated with 60-Day Readmission Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy.Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors with Peritoneal Dissemination after HIPEC.Preoperative platelet-lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Clinicopathologic and Prognostic Features in Patients with Peritoneal Metastasis from Mucinous Adenocarcinoma, Adenocarcinoma with Signet Ring Cells, and Adenocarcinoid of the Appendix Treated with Cytoreductive Surgery and Perioperative IntraperitoCirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients.
P2860
Q26768309-17A1FEF6-0985-439E-86AA-5FCF6E943698Q38601896-B98734A1-2086-46D9-900E-9456AFA86867Q38726776-C7624751-1C7E-4B60-B5DB-18E1B42E6191Q38877138-336CAABD-32E1-4452-B75C-E1605F3777D0Q38925870-657F3E2B-DCD1-46B8-BC6D-DEEBC674F066Q41041625-7E85DF21-614A-4967-8304-99245A151751Q46989085-BBBEDA7E-4817-4F82-A30C-2268E6295CA4Q49545044-4B21F945-166A-4C26-8D63-176202CCCC0FQ51161081-28EC8F82-8D9A-44FE-8F97-83476B758A04Q53272767-D7C0A6E8-BF64-4A47-B710-714AE3BC4A0AQ55058359-D24833F4-F2CA-4F47-A7C5-5F818B4C0BA6
P2860
Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Predictors of progression in h ...... intraperitoneal chemotherapy.
@en
Predictors of progression in h ...... intraperitoneal chemotherapy.
@nl
type
label
Predictors of progression in h ...... intraperitoneal chemotherapy.
@en
Predictors of progression in h ...... intraperitoneal chemotherapy.
@nl
prefLabel
Predictors of progression in h ...... intraperitoneal chemotherapy.
@en
Predictors of progression in h ...... intraperitoneal chemotherapy.
@nl
P2093
P2860
P1476
Predictors of progression in h ...... intraperitoneal chemotherapy.
@en
P2093
Andrew M Lowy
Eric J Roeland
Joel M Baumgartner
Kaitlyn J Kelly
Laura Tobin
Sean F Heavey
P2860
P2888
P304
P356
10.1245/S10434-014-3985-Y
P577
2014-08-22T00:00:00Z
P5875
P6179
1023040223